My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

19.03 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zai Lab Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its 'Impressive' Results ↗

October 24, 2024

The company is working on an antibody drug conjugate, which is like a smart bomb for cancer cells.

Via Investor's Business Daily

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday ↗

October 24, 2024

Via Benzinga

Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 25, 2024

Via Benzinga

Why Is Zynex (ZYXI) Stock Down 24% Today? ↗

July 26, 2024

Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024.

Via InvestorPlace

Topics Earnings

Recap: Zai Lab Q4 Earnings ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

What Happened With Zai Lab Stock? ↗

December 21, 2023

Zai Lab Limited (NASDAQ: ZLAB) shares traded lower on Thursday. The stock has pulled back sharply from recent strength.

Via Benzinga

Analyst Ratings for Zai Lab ↗

November 30, 2023

Via Benzinga

Why Is DexCom (DXCM) Stock Down 38% Today? ↗

July 26, 2024

DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance.

Via InvestorPlace

Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem ↗

July 26, 2024

A compelling hidden-gem opportunity, Zai Lab’s groundbreaking cancer therapeutic and discounted valuation could drive up ZLAB stock.

Via InvestorPlace

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 04, 2024

Via Benzinga

Recap: Zai Lab Q3 Earnings ↗

November 07, 2023

Via Benzinga

Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday ↗

June 04, 2024

Via Benzinga

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 09, 2024

Via Benzinga

Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday ↗

May 09, 2024

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 ↗

May 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 09, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 09, 2024

Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!

Via InvestorPlace

ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion ↗

April 06, 2024

ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates...

Via Talk Markets

One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details ↗

April 01, 2024

Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint not met, safety consistent. Also, positive Phase 3 results for Krazati...

Via Benzinga

Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗

March 20, 2024

Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.

Via InvestorPlace

Stock Disconnect Triggers Investor Exodus From CStone Pharma ↗

March 14, 2024

Key Takeaways: CEO Jason Yang has increased his CStone stake multiple times over the past 18 months to 4.79% of outstanding shares, signaling confidence in the company

Via Benzinga

Top 5 Health Care Stocks That Are Preparing To Pump In February ↗

February 09, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

January 22, 2024

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading...

Via Benzinga

Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday ↗

December 21, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

Via Benzinga

Topics Stocks

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 11, 2023

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...

Via Benzinga

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗

December 11, 2023

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.